Pillstats
Rx only · Kit

Desogestrel And Ethinyl Estradiol

Brands: Averi · Apri 28 Day · Cyred Eq · Enskyce +6

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCG03CA01
RxCUI (US)4124
US makers13 labelers
Packages26
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.060$0.120$0.179$0.239Dec 2025Apr 2026Jul 2026
$0.178
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
13
Active US suppliers
31%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

29K58K87K116K2025 Q12025 Q22025 Q32025 Q42026 Q1
87K
Rx · 2026 Q1
5.2M
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
NorthStar Rx LLCunknown4SUPPLYING
Mayne Pharma Inc.unknown4SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
Camber Pharmaceuticals, Inc.unknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
Xiromed, LLC.unknown2SUPPLYING
Avion Pharmaceuticals, LLCunknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Afaxys Pharma, LLCunknown1SUPPLYING
Naari Pte Limitedunknown1SUPPLYING
Apotex Corp.unknown1SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 17, 2014
    RECALLRecall (Class III): Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/…

    Failed Impurities/Degradation Specifications: out of specification impurity test results. — Recalling firm: Teva Pharmaceuticals USA — Nationwide

  • Jun 17, 2014
    RECALLRecall (Class III): Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva…

    Failed Impurities/Degradation Specifications: out of specification impurity test results. — Recalling firm: Teva Pharmaceuticals USA — Nationwide